It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Discover practical ways to raise money to pay off debt. Take the first step towards a healthier financial future today!
22,262 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Resolute Holdings stock soars can signal a potent momentum move. This guide breaks down the drivers, evaluates sustai...
Nvidia has reportedly extended a new funding round for Nebius, expanding its footprint in AI infrastructure. Analysts...
All 50 states now report average gas prices above $4 per gallon as the summer driving season begins. Analysts warn pr...
The AI IPO buzz around SpaceX, OpenAI, and Anthropic can tempt bold moves. A steadier path for investors is broad-mar...
Starting with $1,000, you can anchor a tech-forward portfolio on three core players. This guide explains why these co...
As volatility climbs in 2026, a tax-savvy move is drawing attention: converting traditional IRAs to Roth IRAs when va...
Investors are debating whether Palantir stock can still deliver. This guide breaks down the growth story, the risks, ...
BlackRock chief executive officer Larry Fink signaled that some AI players will fail as the industry expands, framing...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
As of June 2026, households pursue financial independence by targeting $7,500 a month in dividend income to replace a...
Savers face a fast-moving market where finding best high-yield savings requires careful rate shopping. This report br...